Clinical trials focus on OTOF-associated hearing loss, but other genes identified as appealing next targets

Clinical trials focus on OTOF-associated hearing loss, but other genes identified as appealing next targets
Innovations initially developed for and by the gaming industry have moved into medical clinics and operating rooms.
One of the priceless perks of being a physician/surgeon is having colleagues and friends who can give advice and help us find the best doctor for our own medical needs.
There is a tacit “deal” in American medicine. The “deal” was necessary because of how our education system evolved. In addition, the “deal” was created in partnership with the federal government as a method of providing healthcare to our population and our society. Social programs were adjunctive to the “deal,” and the costs for these programs have grown exponentially over time. The foundation of the “deal” was a trust that there was a shared mission-based integrity. However, there is also the gritty reality of economics behind the “deal.” How should a profession respond when trust is eroded and components of a long-standing relationship are parsed in such a way as to create an undue burden that ignores tenets of goodwill?
Otolaryngologists are uniquely positioned to develop innovations that improve patient care (and ease physician stress), but the path to entrepreneurship isn’t easy or obvious.
Otolaryngologists strongly support diversity, equity, and inclusion (DEI) initiatives in medicine, with 59% of trainees and 86% of practicing otolaryngologists “favoring or strongly favoring” DEI initiatives.
Realistic hope can be beneficial to the patient if developed within the envelope of evidence and experience known by the clinician and bolstered by an honest, informed discussion with the patient.
Repeat operative or clinic-based procedures to debulk papillomatous disease have been the standard of care to date in the treatment of patients with recurrent respiratory papillomatosis (RRP) caused by chronic infection with human papillomavirus (HPV) type 6 or 11. Treatment of RRP is one of the rare instances in medicine of a chronic infection treated with repeat procedural intervention.
Medical students and residents are embracing new technologies to help them study. This shift is driven by advances in artificial intelligence (AI), educational platforms, and other digital tools, along with demands for more flexible and personalized learning.